Perrigo reported $3.28B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
AbbVie USD 62.48B 2.05B Jun/2026
Abbott USD 29.45B 152M Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
Bristol-Myers Squibb USD 41.85B 244M Sep/2026
Coherus Biosciences USD 51.08M 496K Dec/2025
Dr.Reddys Laboratories INR 11.92B 284M Sep/2026
Eli Lilly USD 46.99B 872M Sep/2026
J&J USD 35.8B 1.55B Sep/2026
Merck USD 49.69B 1.39B Sep/2026
Nestle CHF 46.5B 254M Jun/2026
Perrigo USD 3.28B 600K Sep/2026
Pfizer USD 60B 498M Sep/2026
Phibro Animal Health USD 585.85M 11.83M Sep/2026
Prestige Brands USD 2.08B 54.81M Sep/2026
Reckitt Benckiser GBP 7.24B 590M Dec/2024
Sanofi EUR 16.28B 1.63B Sep/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 12.68B 588M Sep/2026
Xeris Pharmaceuticals USD 189.71M 906K Sep/2026
Zoetis USD 8.3B 749M Sep/2026